The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Breast Cancer Diagnostics Market Across 2026–2030?
The market for breast cancer diagnostics has experienced robust growth recently. This market is projected to expand from $5 billion in 2025 to $5.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this expansion has been driven by factors such as a global increase in breast cancer cases, greater public understanding of early cancer detection, the development of diagnostic imaging facilities, the increasing supply of tests based on biomarkers, and advancements in the precision and safety of biopsies.
The breast cancer diagnostics market is projected to undergo significant expansion in the upcoming years. It is forecast to attain a value of $7.28 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. The anticipated growth within this period stems from the increasing integration of precision oncology diagnostics, rising investments directed towards AI-enabled diagnostic platforms, an escalating demand for minimally invasive testing procedures, the widening reach of population-based screening programs, and ongoing progress in molecular diagnostic technologies. Notable trends expected during the forecast period encompass a greater adoption of AI-assisted imaging analysis, an increased utilization of genomic and molecular testing, the growing deployment of liquid biopsy techniques, the expansion of advanced non-ionizing imaging modalities, and an intensified focus on prompt and personalized diagnoses.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp
What Drivers Are Shaping The Future Growth Of The Breast Cancer Diagnostics Market?
Public sector programs and financial aid for breast cancer are anticipated to fuel expansion in the breast cancer diagnostics market in the future. These initiatives and funds represent governmental financial backing extended to specific organizations or projects designed to enhance public services and economic conditions. Such government support is crucial for advancing breast cancer research, prevention, and treatment, involving diverse programs aimed at increasing awareness, encouraging early diagnosis via screening and mammography, and offering financial aid for breast cancer testing and treatment in underprivileged areas. As an illustration, The Australian Government Department of Health (DoH), a government body based in Australia, committed $40.7 million in its 2022-23 budget. This allocation aimed to improve access to testing and screening services for multiple cancer types, addressing delays from the COVID-19 pandemic, and facilitating quick referrals, rapid diagnosis, and early interventions, with $9.7 million specifically designated for breast cancer screening. Consequently, governmental programs and financial support directed towards breast cancer are propelling the expansion of the breast cancer diagnostics market.
What Segmentation Levels Are Considered In The Breast Cancer Diagnostics Market?
The breast cancer diagnostics market covered in this report is segmented –
1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, Triple-Negative Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers
Subsegments:
1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis
2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy
3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing
4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests
5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing
What Trends Are Projected To Affect The Breast Cancer Diagnostics Market?
Leading companies in the breast cancer diagnostics market are prioritizing the development of innovative AI-driven diagnostic solutions, such as advanced pathology scoring platforms, to enhance accuracy, streamline workflows, and enable personalized treatment planning. These AI-based diagnostic platforms utilize machine learning and deep-learning algorithms to analyze medical imaging, pathology slides, or clinical data, providing diagnostic insights or risk stratifications that support clinical decision-making. For example, in September 2024, Ibex Medical Analytics, an Israel-based digital pathology company, introduced its expanded AI platform for breast cancer diagnostics, which includes a fully automated zero-click HER2 immunohistochemistry (IHC) scoring feature within its Ibex Breast HER2 module. This specific tool effectively identifies invasive cancer areas, classifies HER2 expression levels (0, 1+, 2+, 3+), and contributes to improved accuracy and workflow efficiency in breast cancer diagnosis and treatment-pathway decisions.
Which Leading Firms Are Contributing To The Growth Of The Breast Cancer Diagnostics Market?
Major companies operating in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.
Read the full breast cancer diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report
Which Geographic Regions Are Influencing Demand In The Breast Cancer Diagnostics Market?
North America was the largest region in the breast cancer diagnostics market in 2025. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Breast Cancer Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp
Browse Through More Reports Similar to the Global Breast Cancer Diagnostics Market 2026, By The Business Research Company
Next Generation Gynecological Cancer Diagnostics Market Report 2026
Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Breast Imaging Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/breast-imaging-technologies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model